NISSUI CORPORATION
1-3-1
NISHISHIMBASHI NISHISHIMBASHI SQUARE MINATO-KU
TOKYO
105-0003 Japan
Nissui Q3 2025: Double-Digit Profit Growth Driven by Aquaculture & North America
Nissui reports strong Q3 2025 results with 26.5% operating profit growth, driven by aquaculture recovery and North American processing. The article details segment performance and strategic plans under 'Good Foods Recipe 2'.
Source: IndexBox Feb 9, 2026
Asian Stock Markets Mixed as Investors Weigh Potential US Fed Move After Jobs Data
Asian stock markets closed mixed Wednesday as traders digested the latest US jobs data and mulled po
Source: MT Newswires Dec 17, 2025
Japan’s Nissui snaps up Chilean salmon business Pesquera Yadran
The deal, struck with a group of investors, has been signed off for $133m.
Source: Just Food Dec 16, 2025
A Look at Nissui (TSE:1332) Valuation Following Second Quarter Dividend Increase
Nissui (TSE:1332) has announced a boost to its second quarter-end dividend, raising it to JPY 14.00 per share for the current fiscal year. This is up from JPY 12.00 a year earlier. See our latest analysis for Nissui. The positive dividend hike comes amid a strong run for Nissui, with the stock delivering a 19.8% share price return over the last 90 days and a standout 30.4% total shareholder return in the past year. The company’s long-term total returns are even more impressive. This...
Source: Simply Wall St. Nov 14, 2025
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
The partnership involves the implementation of the CMS-WS server and CAYIN Signage Player.
Source: Hotel Management Network Sep 9, 2025
Nifty clocks fifth session of gains led by IT on Infosys buyback, US rate cut hopes
India's benchmark Nifty 50 closed higher for a fifth consecutive session on Tuesday, with gains led by information technology stocks on Infosys' share buyback plan and U.S. interest rate cut prospects. The Nifty 50 and the BSE Sensex gained 0.39% each to 24,868.6 and 81,101.32 points, respectively. IT jumped 2.8%, led by a 5% surge in Infosys after it announced plans to consider a share buyback on September 11.
Source: Reuters Sep 9, 2025
- Frozen tuna
- Canned sardines
- Fish fillets
- Shrimp
- Fish roe
- Caviar
- Seaweed salad
- Fish oil
- Fish meal
- Frozen octopus
- Fish sauce
- Fish collagen
- Fish protein powder
- Fish skin leather
- Fish feed
- Fish gelatin
- Fish scale jewelry
- Fish leather wallet
- Fish bone broth
- Fish skin chips
- Fish oil capsules
- Fish protein bars
- Fish jerky
- Fish collagen drink
- Fish scale art
- Fish bone fertilizer
- Fish leather shoes
- Fish scale mosaic tiles
- Fish collagen face mask
- Fish bone china dinnerware
- Fish fillets
- Frozen shrimp
- Fish roe
- Fish oil
- Fish meal
- Fish sauce
- Seafood seasoning
- Fish collagen
- Fish protein powder
- Fish skin leather
- Fish feed
- Fish bone meal
- Fish leather wallets
- Fish leather bags
- Fish collagen supplements
- Fish skin chips
- Fish skin snacks
- Fish oil supplements
- Fish protein bars
- Fish bone broth
- Fish oil capsules
- Fish protein shakes
- Fish collagen drinks
- Fish leather shoes
- Fish collagen beauty products
- Canned tuna
- Fish fertilizer
- Fish jerky
- Fish sausages
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.